09:51 AM EDT, 07/31/2025 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) reported Thursday Q2 net loss of $1.93 per diluted share, widening from a loss of $1.69 a year earlier.

Analysts polled by FactSet expected a loss of $1.68.

Revenue for the quarter ended June 30 was $12.5 million, up from $8.6 million a year earlier.

Analysts polled by FactSet expected $9.5 million.

Shares were down 1% in recent early trading.

Price: 37.33, Change: -0.21, Percent Change: -0.55